Achaogen Inc. appointed president and COO Blake Wise to the position of CEO, effective Jan. 1, 2018.
Wise will also be appointed to the company's board.
Wise succeeds Kenneth Hillan, who is taking on the newly created role of president of research and development. In addition, Hillan will be the president of the company and will remain on the board.
